Literature DB >> 1757943

Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis.

E H Giannini1, C N Malagon, C Van Kerckhove, J Taylor, D J Lovell, J E Levinson, M H Passo, J Ginsberg, M J Burke, D N Glass.   

Abstract

The risk of iridocyclitis in children with early onset pauciarticular juvenile rheumatoid arthritis (EOPA-JRA) has been shown to be associated with certain HLA haplotypes. Our report contains an actuarial analysis, using one-year intervals, of 161 subjects and estimates haplotype specific risks. Individuals who possess the major susceptibility haplotype HLA-DR5 (11) developed eye disease earlier and with a greater frequency than did those with the protective HLA-DR1 haplotype. Highly significant differences were found between the resulting life-table curves for HLA-DR5 and HLA-DR1 positive subjects (p = 0.00003). These time oriented risk estimates may aid clinicians in determining more precisely the probability of iridocyclitis throughout the course of the disease in children with EOPA-JRA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757943

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 2.  Pathogenesis of juvenile chronic arthritis: genetic and environmental factors.

Authors:  K Murray; S D Thompson; D N Glass
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

Review 3.  Uveitis associated with juvenile idiopathic arthritis.

Authors:  Ethan S Sen; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

Review 4.  Uveitis in children.

Authors:  Sheila T Angeles-Han; Consuelo Egla Rabinovich
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

5.  HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Se Ryeong Jang; Kirsten Jenkins; Spencer Cope; John Bohnsack; Aimee Hersh; Susan D Thompson; Sampath Prahalad
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

Review 6.  Prevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila Angeles-Han; Steven Yeh
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

7.  Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila T Angeles-Han; Steven Yeh; Larry B Vogler
Journal:  Int J Clin Rheumtol       Date:  2013-02-01

8.  Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.

Authors:  Tamas Constantin; Ivan Foeldvari; Jordi Anton; Joke de Boer; Severine Czitrom-Guillaume; Clive Edelsten; Raz Gepstein; Arnd Heiligenhaus; Clarissa A Pilkington; Gabriele Simonini; Yosef Uziel; Sebastian J Vastert; Nico M Wulffraat; Anne-Mieke Haasnoot; Karoline Walscheid; Annamária Pálinkás; Reshma Pattani; Zoltán Györgyi; Richárd Kozma; Victor Boom; Andrea Ponyi; Angelo Ravelli; Athimalaipet V Ramanan
Journal:  Ann Rheum Dis       Date:  2018-03-28       Impact factor: 19.103

Review 9.  How does age determine the development of human immune-mediated arthritis?

Authors:  Yannick Degboe; Sebastiaan J Vastert; Berent J Prakken; Iain B McInnes
Journal:  Nat Rev Rheumatol       Date:  2022-08-10       Impact factor: 32.286

Review 10.  Juvenile idiopathic arthritis-associated uveitis.

Authors:  Sarah L N Clarke; Ethan S Sen; Athimalaipet V Ramanan
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-27       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.